Back to search

Japan· JP-4490005F1573

オキサトミド

A oxatomide product containing オキサトミド, registered in Japan by 日本薬品工業, on the national reimbursement list. The same ATC class is registered in 2 of our 19 countries.

On Japan’s NHI price listATC R06AE06

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedオキサトミドATCR06AE06REGISTER NO.JP-4490005F1573PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Oxatomide is registered in 2 of 19 countries.

Countries holding a registration under ATC R06AE06 (oxatomide), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 1 of them publish a price we can compare per daily dose

Oxatomide · ATC R06AE06

2 / 19 countries

  • Italyprice
  • Japan
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxatomide costs, country by country.

Normalised to the WHO defined daily dose (60 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Oxatomide · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • IT Italy$0.41
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
オキサトミド
Manufacturer
日本薬品工業
Country
Japan (JP)
ATC code
R06AE06
ATC class
Oxatomide
Defined daily dose
60 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7a3ea04d-d8c7-48d8-9e2c-d3732d967e82
GET /v1/drugs/7a3ea04d-d8c7-48d8-9e2c-d3732d967e82?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "30mg1錠",
  "marks": null,
  "source": "mhlw",
  "remarks": null,
  "yj_code": "4490005F1573",
  "category": "内用薬",
  "price_yen": 12.7,
  "generic_name": "オキサトミド",
  "product_name_jp": null,
  "therapeutic_class": "4490",
  "transitional_expiry": "R9.3.31まで"
}

See everything about oxatomide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.